HAIFA, Israel May 13, 2013 - Pluristem Therapeutics Inc. (NASDAQCM: PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today its PLacental eXpanded (PLX) cells tested in preclinical animal models of preeclampsia ...

Pluristem Therapeutics Inc. : Pluristem and United Therapeutics Enter into an Exclusive License Agreement to Develop and Commercialize PLX Cells for the Treatment of Pulmonary Hypertension.

HAIFA, Israel April 29, 2013 - Pluristem Therapeutics Inc. (NASDAQCM: PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that independent researchers from the Queensland Lung Transplant Service at the University ...

HAIFA, Israel, April 18, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today it is expanding its presence in the orthopedic and sports medicine markets ...

Pluristem Therapeutics Inc. (NASDAQ:PSTI) moved up 5.26% to $3.08 on a traded volume of 11k shares. The Company is expanding its presence in the orthopedic and sports medicine markets with plans to initiate a Phase I clinical trial to evaluate the ...

HAIFA, Israel, April 30, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today the company is scheduled to participate in the following investment ...

The PLX cells were created and patented by Israeli-based Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapies.

If we compare what Osiris Therapeutics Inc. (OSIR:NASDAQ), Athersys Inc. (ATHX:NASDAQ), Pluristem Therapeutics Inc. (PSTI:NASDAQ) and Mesoblast are doing, they all have different variations of an allogeneic product (using cells from the same species).

Blech pleaded guilty last year to two counts of securities fraud, admitting that he tried to manipulate the value of a biotech company, Pluristem Therapeutics Inc., after investing more than $1 million in it in late 2006. He said at the plea that he ...

Pluristem Therapeutics Inc (NASDAQ:PSTI) - Pluristem Therapeutics Inc., a bio-therapeutics company, engages in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of life ...